Related references
Note: Only part of the references are listed.Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis
Barbara Vigone et al.
RHEUMATOLOGY (2015)
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
L. van Bon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression
Zana Brkic et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank van den Hoogen et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis
Xiaochun Liu et al.
ARTHRITIS AND RHEUMATISM (2013)
CXCL13 and B-cell activating factor as putative biomarkers in systemic sclerosis
N. Wutte et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
The interferon signature in autoimmune diseases
Lars Ronnblom et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
Brandon W. Higgs et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
B Cell and BAFF Dependence of IFN-α-Exaggerated Disease in Systemic Lupus Erythematosus-Prone NZM 2328 Mice
Noam Jacob et al.
JOURNAL OF IMMUNOLOGY (2011)
Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus
Gina S. Garcia-Romo et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts
Sandeep K. Agarwal et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Type I interferon system activation and association with disease manifestations in systemic sclerosis
Maija-Leena Eloranta et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
A Four-Gene Biomarker Predicts Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
G. Farina et al.
ARTHRITIS AND RHEUMATISM (2010)
Polymorphisms in TBX21 and STAT4 Increase the Risk of Systemic Sclerosis Evidence of Possible Gene-Gene Interaction and Alterations in Th1/Th2 Cytokines
Pravitt Gourh et al.
ARTHRITIS AND RHEUMATISM (2009)
STAT4 Is a Genetic Risk Factor for Systemic Sclerosis Having Additive Effects With IRF5 on Disease Susceptibility and Related Pulmonary Fibrosis
P. Dieude et al.
ARTHRITIS AND RHEUMATISM (2009)
Association of a Functional Polymorphism in the IRF5 Region With Systemic Sclerosis in a Japanese Population
Ikue Ito et al.
ARTHRITIS AND RHEUMATISM (2009)
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype
B. Rueda et al.
HUMAN MOLECULAR GENETICS (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Induction of interferon-α by scleroderma sera containing autoantibodies to topoisomerase I
Daniel Kim et al.
ARTHRITIS AND RHEUMATISM (2008)
Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma
Hangjun Duan et al.
ARTHRITIS AND RHEUMATISM (2008)
Autoantibodies and Microvascular Damage Are Independent Predictive Factors for the Progression of Raynaud's Phenomenon to Systemic Sclerosis A Twenty-Year Prospective Study of 586 Patients, With Validation of Proposed Criteria for Early Systemic Sclerosis
Martial Koenig et al.
ARTHRITIS AND RHEUMATISM (2008)
Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification
Paul A. Lyons et al.
BMC GENOMICS (2007)
A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I Interferons and Toll-like receptor agonists
Michael R. York et al.
ARTHRITIS AND RHEUMATISM (2007)
A relative resistance of T cells to dexamethasone in bipolar disorder
Esther M. Knijff et al.
BIPOLAR DISORDERS (2006)
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients
FK Tan et al.
RHEUMATOLOGY (2006)
Elevated serum BAFF levels in patients with systemic sclerosis - Enhanced BAFF signaling in systemic sclerosis B lymphocytes
T Matsushita et al.
ARTHRITIS AND RHEUMATISM (2006)
Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion
FJT Staal et al.
JOURNAL OF IMMUNOLOGY (2004)
Coordinate overexpression of interferon-α-induced genes in systemic lupus erythematosus
KA Kirou et al.
ARTHRITIS AND RHEUMATISM (2004)
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program
E Beillard et al.
LEUKEMIA (2003)
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
EA Leadbetter et al.
NATURE (2002)
Share Paper
